The latest thoracic oncology news
Combining the PD-1 immune check point inhibitor nivolumab with the monoclonal antibody ipilimumab showed a…
Video-assisted thoracic surgery is associated with lower in-hospital complications and shorter length of stay compared…
Selpercatinib was granted Breakthrough Therapy Designation by the U.S. Food & Drug Administration in 2018…
It’s well known that keeping blood glucose levels in check can help individuals avoid or…
Here is ecancer’s speedy recap on the presentations from the 2019 American Society of Clinical…
A study looking at 10,500 health records of advanced non-small cell lung cancer (aNSCLC) patients…
Initial results of NRG-LU001 indicate that, although the diabetes agent metformin was well-tolerated by patients,…
Crizotinib and entrectinib are both active against ROS1 non-small cell lung cancer. But which is…
Neoadjuvant, or pre-surgical, treatment with nivolumab plus ipilimumab resulted in an overall major pathologic response…
Five-year data from the phase Ib KEYNOTE-001 clinical trial show that pembrolizumab was safe and…